Year: 2026
Type: preprint
Abstract: ABSTRACT HIV-1 integrase (IN) performs two essential functions in virus replication: catalyzing the integration of reverse-transcribed viral cDNA into host DNA and promoting proper virion maturation. The latter is mediated by IN binding to the genomic RNA (gRNA) through basic residues in its C- terminal domain (CTD), thereby ensuring correct repackaging of the gRNA inside the remodeled capsid lattice. Allosteric integrase inhibitors (ALLINIs) bind within a V-shaped pocket at the interface of the catalytic core domain (CCD) of IN dimers, promote the engagement of the CTDs from adjacent dimers, and thereby occlude gRNA binding. However, virological evidence supporting a role for the IN-CTD in ALLINI mechanism of action is lacking, as mutations in CTD residues implicated in ALLINI-induced multimerization typically yield non-infectious viruses. Here we demonstrate that IN-CTD mutants bearing compensatory substitutions that restore infectivity exhibit markedly altered sensitivity to ALLINIs. Specifically, we show that R269A/K273A substitutions within the IN-CTD confer ∼100-fold enhanced sensitivity to ALLINIs. This correlates with a loss of IN-gRNA binding at low ALLINI concentrations, while exerting minimal effects on IN multimerization in vitro and in virions. In contrast, we found that the IN I268T substitution which arose as a suppressor mutation of I268A confers partial resistance to ALLINI-induced inhibition of gRNA binding. Collectively, these findings provide the first direct genetic evidence that CTD residues, despite being distal to the primary drug binding site at the CCD dimer, modulate sensitivity to ALLINIs and highlights IN-gRNA binding as a central target of ALLINIs. SIGNIFICANCE In addition to its catalytic role in viral DNA integration, HIV-1 integrase (IN) is essential for virion maturation. IN binding to the viral RNA genome (gRNA) through basic residues in its C-terminal domain (CTD) ensures the proper repackaging of the gRNA inside the mature capsid lattice. Allosteric integrase inhibitors (ALLINIs) bind to a pocket within the catalytic core domain (CCD) of an IN dimer and are thought to disrupt IN-gRNA interactions by triggering aberrant IN multimerization through the engagement of the CTDs of a nearby dimer. However, direct genetic evidence supporting a role for the IN-CTD in ALLINI mechanism of action is lacking. Herein, we show that IN-CTD mutants bearing compensatory substitutions that restore infectivity have significantly altered sensitivities against ALLINIs. Our findings provide the first virological evidence that residues within the CTD, away from the primary drug binding site at the CCD dimer, can alter ALLINI sensitivity.
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7223549048